<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR28">
 <label>28.</label>
 <mixed-citation publication-type="other">The ASCO Post. FDA approves larotrectinib for solid tumors with NTRK gene fusion. Dec 27, 2018. Available at 
  <ext-link ext-link-type="uri" xlink:href="https://ascopost.com/News/59498" xmlns:xlink="http://www.w3.org/1999/xlink">https://ascopost.com/News/59498</ext-link>
 </mixed-citation>
</ref>
